Advanced Search

Technical Analysis for RNLX - Renalytix AI plc

Grade Last Price % Change Price Change
F 24.08 -1.99% -0.49
RNLX closed down 1.99 percent on Monday, April 12, 2021, on 73 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical RNLX trend table...
Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Doji - Bearish? Reversal 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.99%
Narrow Range Bar Range Contraction -1.99%
NR7 Range Contraction -1.99%
Inside Day Range Contraction -1.99%
Older End-of-Day Signals for RNLX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 3 hours ago
Outside Day about 3 hours ago
Down 2 % about 3 hours ago
Non-ADX 1,2,3,4 Bearish Retracement Entry about 3 hours ago
Fell Below Previous Day's Low about 3 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
RenalytixAI is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs. Our goal is to lower healthcare costs and improve patient quality of life by transforming the paradigm for kidney disease risk assessment and clinical management through our KidneyIntelX platform.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Artificial Intelligence Medical Technology Kidney Disease In Vitro Health Informatics Risk Assessment Quality Of Life In Vitro Diagnostics Healthcare Costs Artificial Intelligence Applications Clinical Management

Is RNLX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Apr 8 Clinical Utility Study Demonstrates Primary Care Physicians Highly Likely to Order KidneyIntelX to Inform Care Decisions
Apr 5 RenalytixAI's KidneyIntelX is more effective in identifying kidney disease than standard of care
Apr 5 Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure
Mar 15 Renalytix rules out impact from changes to implementation of MCIT rule
Mar 15 Update on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics
Mar 12 The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs
Mar 10 Kantaro Biosciences Named to Fast Company's Annual List of the World's Most Innovative Companies for 2021 and Ranked First in the Joint Ventures Category
Mar 4 Renalytix AI plc Issue of Shares Under the 2020 Employee Share Purchase Plan, PDMR Dealing and Total Voting Rights
Mar 3 COVID-19 Convalescent Plasma Study Shows No Benefit, US NIH Stops Trial
Mar 2 Renalytix AI EPS misses by $0.08, misses on revenue
See more RNLX news...

Indicators

Indicator Value
52 Week High 32.11
52 Week Low 9.91
Average Volume 118,909
200-Day Moving Average 0.00
50-Day Moving Average 26.36
20-Day Moving Average 26.87
10-Day Moving Average 24.82
Average True Range 1.93
ADX 26.66
+DI 14.76
-DI 19.16
Chandelier Exit (Long, 3 ATRs ) 26.31
Chandelier Exit (Short, 3 ATRs ) 29.22
Upper Bollinger Band 31.53
Lower Bollinger Band 22.21
Percent B (%b) 0.2
BandWidth 34.68
MACD Line -0.74
MACD Signal Line -0.29
MACD Histogram -0.4497
Fundamentals Value
Market Cap 867.24 Million
Num Shares 36 Million
EPS -0.26
Price-to-Earnings (P/E) Ratio -94.06
Price-to-Sales 2769.46
Price-to-Book 5.21
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.37
Resistance 3 (R3) 27.70 26.95 26.82
Resistance 2 (R2) 26.95 26.11 26.78 26.63
Resistance 1 (R1) 25.51 25.59 25.14 25.18 26.45
Pivot Point 24.76 24.76 24.57 24.59 24.76
Support 1 (S1) 23.32 23.92 22.95 22.99 21.71
Support 2 (S2) 22.57 23.40 22.40 21.53
Support 3 (S3) 21.13 22.57 21.34
Support 4 (S4) 20.80